Michael B. Jebsen
2017
In 2017, Michael B. Jebsen earned a total compensation of $595.9K as President, Interim Chief Executive Officer and Chief Financial Officer at Tenax Therapeutics, a 15% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $82,875 |
|---|---|
| Option Awards | $92,563 |
| Salary | $420,417 |
| Total | $595,855 |
Jebsen received $420.4K in salary, accounting for 71% of the total pay in 2017.
Jebsen also received $82.9K in non-equity incentive plan and $92.6K in option awards.
Rankings
In 2017, Michael B. Jebsen's compensation ranked 11,226th out of 14,666 executives tracked by ExecPay. In other words, Jebsen earned more than 23.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,226 out of 14,666 | 24th |
Division Manufacturing | 4,395 out of 5,768 | 24th |
Major group Chemicals And Allied Products | 1,594 out of 2,074 | 23rd |
Industry group Drugs | 1,312 out of 1,730 | 24th |
Industry Pharmaceutical Preparations | 1,025 out of 1,329 | 23rd |
Source: SEC filing on April 20, 2018.
Jebsen's colleagues
We found one more compensation record of an executive who worked with Michael B. Jebsen at Tenax Therapeutics in 2017.
2017
John Kelley
Tenax Therapeutics